Jonathan Berlent is Chief Business Officer of Cure Pharmaceutical Holding Corp.. Currently has a direct ownership of 10,000 shares of CURR, which is worth approximately $900. The most recent transaction as insider was on May 27, 2021, when has been sold 10,000 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $6,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $900

Jonathan Berlent Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 27 2021
BUY
Open market or private purchase
$6,900 $0.69 p/Share
10,000 Added 50.0%
10,000 Common Stock
JB

Jonathan Berlent

Chief Business Officer
Oxnard, CA

Track Institutional and Insider Activities on CURR

Follow Cure Pharmaceutical Holding Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CURR shares.

Notify only if

Insider Trading

Get notified when an Cure Pharmaceutical Holding Corp. insider buys or sells CURR shares.

Notify only if

News

Receive news related to Cure Pharmaceutical Holding Corp.

Track Activities on CURR